New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Clever Leaves Holdings Inc.
CLVR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

351

Drug Manufacturers - Specialty & Generic

Next Earning date - 31 Mar 2025

351

Drug Manufacturers - Specialty & Generic

Next Earning date - 31 Mar 2025

0.00USD

Shape0.00 ( 18.18%)
moonAfter-hours 0.00$arrow-left-down-0.00 (-100.00%)
Market Closed (as of Feb 19, 16:16 EDT)
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-98%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated March 27, 2025
1W 100.00 % 1M -83.33 % 3M -99.20 % 1Y -100.00 %

Key Metrics

Shape
  • Market Cap

    351


  • Shares Outstanding

    1.75M


  • Share in Float

    1.70M


  • Dividende

    0


  • Earning Date

    31 Mar 2025


  • Price Target

    0.0002


  • Average Volume

    832


  • Beta

    81.73


  • Range

    0.0001-5.8899


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cleverleaves.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CLVR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$30M

Shape547%

2024-Revenue

$6.60

Shape-124%

2024-EPS

$30M

Shape-549%

2024-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2022-08-01

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-15.62
vs -16.50

Q2.22

arrow
arrow

N/A

-6.01
vs -12.01

Q3.22

arrow
arrow

N/A

-5.71
vs -13.21

Q4.22

arrow
arrow

N/A

-3.90
vs -5.11

Q1.23

arrow
arrow

N/A

-2.70
vs -15.62

Q2.23

arrow
arrow

N/A

-2.10
vs -6.01

Q3.23

arrow
arrow

N/A

-4.60
vs -5.71

Q4.23

arrow
arrow

N/A

-2.95
vs -3.90

Q1.24

arrow
arrow

+158%

1.58
vs -2.70

Q2.24

arrow
arrow

+164%

1.34
vs -2.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+50%

5.2M  vs 3.5M

Q2.22

arrow
arrow

+12%

4.1M  vs 3.7M

Q3.22

arrow
arrow

-29%

2.9M  vs 4M

Q4.22

arrow
arrow

+10%

4.6M  vs 4.2M

Q1.23

arrow
arrow

-24%

4M  vs 5.2M

Q2.23

arrow
arrow

+21%

5M  vs 4.1M

Q3.23

arrow
arrow

+33%

3.8M  vs 2.9M

Q4.23

arrow
arrow

+1%

4.6M  vs 4.6M

Q1.24

arrow
arrow

+23%

4.9M  vs 4M

Q2.24

arrow
arrow

+4%

5.2M  vs 5M

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-30%

-0.30
vs -0.33

Q2.22

arrow
arrow

-1%

-0.01
vs -0.30

Q3.22

arrow
arrow

-29%

-0.29
vs -0.01

Q4.22

arrow
arrow

-71%

-0.71
vs -0.29

Q1.23

arrow
arrow

-11%

-0.11
vs -0.71

Q2.23

arrow
arrow

-11%

-0.11
vs -0.11

Q3.23

arrow
arrow

-17%

-0.17
vs -0.11

Q4.23

arrow
arrow

-21%

-0.21
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

46

46
vs 36

28%

Q4.21

arrow
arrow

50

50
vs 46

9%

Q1.22

arrow
arrow

51

51
vs 50

2%

Q2.22

arrow
arrow

43

43
vs 51

-16%

Q3.22

arrow
arrow

38

38
vs 43

-12%

Q4.22

arrow
arrow

39

39
vs 38

3%

Q1.23

arrow
arrow

31

31
vs 39

-21%

Q2.23

arrow
arrow

31

31
vs 31

NA

Earnings Growth

Latest News